Segment reporting (Tables)

3 Months Ended

Nov. 30, 2020

Segment Reporting [Abstract]

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reflects results of operations of the Company's reportable segments (in millions):

	Three months ended November 30,
	2020		2019
Sales:
Retail Pharmacy USA	$	27,163	$	26,133
Retail Pharmacy International	2,574		2,745
Pharmaceutical Wholesale	7,125		6,007
Eliminations1	(555)		(545)
Walgreens Boots Alliance, Inc.	$	36,307	$	34,339
Adjusted Operating income:
Retail Pharmacy USA	$	989	$	1,155
Retail Pharmacy International	84		79
Pharmaceutical Wholesale	244		229
Eliminations1	1		—
Walgreens Boots Alliance, Inc.	$	1,318	$	1,463

1Eliminations relate to intersegment sales between the Pharmaceutical Wholesale and the Retail Pharmacy International segments.

The following table reconciles adjusted operating income to operating income (loss) (in millions):

	Three months ended November 30,
	2020		2019
Adjusted operating income	$	1,318	$	1,463
Adjustments to equity earnings (loss) in AmerisourceBergen	(1,481)		(80)
Acquisition-related amortization	(116)		(118)
Transformational cost management	(104)		(86)
LIFO provision	(33)		(33)
Acquisition-related costs	(23)		(124)
Store optimization	—		(9)
Operating income (loss)	$	(440)	$	1,013